Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions
Author:
Lam Wing KitORCID,
Ha Chung Yin,
Yip Sze Fai
Reference87 articles.
1. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463-493. doi: 10.1111/odi.12446.
2. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976;73(10):3685-3689. doi: 10.1073/pnas.73.10.3685.
3. Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974;9(4):285-315. doi: 10.1016/0009-2797(74)90019-2.
4. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312(3):137-141. doi: 10.1056/NEJM198501173120301.
5. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-7. doi: 10.7326/0003-4819-140-7-200404060-00010.